slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,471
Current window 37,831-37,860
Pages 3,950
Rows per page 30
Component
37,831-37,860 of 118,471
29
Avenue Therapeutics | IPO Presentation Deck | 30 slidesAvenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank Beat · Team2 hits
19
Includes footnotes explaining the composition of 'All Other' and specific tax credit adjustments.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI Overview2 hits
01
The brain graphic is a stylized circuit board, representing the intersection of neuroscience and technology.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 2 hits
03
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Problem2 hits
18
SAD likely stands for Social Anxiety Disorder. The diagram uses a circular flow to represent the internal conflict.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 2 hits
22
The slide displays a snippet of the LSAS questionnaire, showing the scoring criteria for 'Fear or Anxiety' and 'Avoidance' and providing examples of the 24 items.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution2 hits
39
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 2 hits
01
BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slidesBrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · Problem2 hits
16
The slide uses a timeline-style process diagram to show the progression of the 'trail'.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet2 hits
01
The slide features a prominent image of a Nasdaq billboard in Times Square.Business First Bancshares | IPO Presentation Deck | 47 slides · Business First Bancshares
Pitch deck Investment bank 2 hits
01
Includes Exhibit 99.1 reference, typical for SEC-filed investor decks.Cabaletta Bio | Investor Presentation Deck | 23 slides · Cabaletta Bio
Pitch deck Investor relations 2 hits
16
Includes detailed scientific citations and specific cohort dosing strategies.Cabaletta Bio | Investor Presentation Deck | 23 slides · Cabaletta Bio
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
18
Includes specific dosing details and regulatory designations (Orphan Drug, Fast Track).Cabaletta Bio | Investor Presentation Deck | 23 slides · Cabaletta Bio
Pitch deck Investor relations 2 hits
05
Includes presenter name, title, and date.Credit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations 2 hits
01
Credit Suisse | Results Presentation Deck | 26 slidesCredit Suisse | Results Presentation Deck | 26 slides · Credit Suisse
Conference presentation Investor relations Beat · Attention2 hits
02
CURO Group Holdings | Credit Presentation Deck | 23 slidesCURO Group Holdings | Credit Presentation Deck | 23 slides · CURO
Pitch deck Investor relations 2 hits
04
Uses a contrast-based argument: low research investment vs. high market performance.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations Loop · Golden Circle2 hits
09
Includes regulatory status and financial terms of the licensing deal.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 2 hits
10
Slide highlights clinical development status and key value propositions for two lead assets.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 2 hits
16
Includes regulatory status and commercial partnership details.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations Beat · Product2 hits
26
The slide uses a comparison framework to map user needs to product capabilities.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations Beat · Solution2 hits
30
The slide highlights the lack of existing FDA-approved therapies for FSAD.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 2 hits
31
Uses a visual inequality symbol to emphasize the distinction between FSAD and HSDD.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 2 hits
34
The slide outlines the methodology and status of a clinical trial.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 2 hits
36
Includes both tabular pharmacokinetic data and a line chart showing plasma concentration over time.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 2 hits
40
The slide uses a side-by-side comparison structure to link the biological rationale with the technical solution.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 2 hits
41
The slide highlights the lack of FDA-approved monthly IVR options for combined hormone therapy.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 2 hits
44
The slide highlights the regulatory pathway (505(b)(2)) and the specific patient population (HR+ breast cancer survivors).Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 2 hits
45
The slide presents clinical trial data comparing baseline to month 3 outcomes and systemic absorption levels.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 2 hits
46
The slide details the methodology of a clinical trial, including randomization, dosing groups, and primary/secondary endpoints.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 2 hits